Ignite Creation Date:
2024-05-06 @ 7:26 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02530476
Status:
COMPLETED
Last Update Posted:
2020-03-31
First Post:
2015-08-19
Brief Title:
Phase III Study of Selective Inhibitor of Nuclear Export SINE Selinexor KPT-330 Sorafenib in Acute Myeloid Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-19
First Submit QC Date:
August 19 2015
Study First Post Date:
2015-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-03-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-18
Last Update Post Date:
2020-03-31
Last Update Post Date Type:
ACTUAL